ASTA FUNDING, INC. (NASDAQ:ASFI) Files An 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On May 30, 2017, Asta Funding, Inc. (the “Company”) received a letter from Nasdaq (“Nasdaq”) stating that, in light of the Company’s May 26, 2017 filing of its Quarterly Report on Form 10-Q for the period ended March 31, 2017, Nasdaq determined that the Company has regained compliance with Nasdaq’s continued listing requirements set forth in Nasdaq Listing Rule 5250(c)(1).
On May 30, 2017, the Company issued a press release announcing its receipt of the letter. A copy of the Company’s press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
99.1 Press Release dated May 30, 2017
About ASTA FUNDING, INC. (NASDAQ:ASFI)
Asta Funding, Inc. is primarily engaged in the businesses of acquiring, managing, servicing and recovering on portfolios of consumer receivables. The Company operates through four segments: Consumer Receivables, Personal Injury Claims, Structured Settlements and GAR Disability Advocates. The Consumer receivables segment is engaged in purchasing, managing for its own account and servicing distressed consumer receivables, including charged off receivables, semi-performing receivables and performing receivables. The Personal injury claims segment includes the operations of its subsidiary, Pegasus Funding, LLC. The Structured settlements segment includes the operations of CBC Settlement Funding, LLC (CBC). The GAR Disability Advocates segment includes the operations of GAR Disability Advocates, LLC (GAR Disability Advocates). GAR Disability Advocates is a social security benefit and disability advocacy group. ASTA FUNDING, INC. (NASDAQ:ASFI) Recent Trading Information
ASTA FUNDING, INC. (NASDAQ:ASFI) closed its last trading session down -0.05 at 6.80 with 1,260 shares trading hands.